First Time Loading...

Femasys Inc
NASDAQ:FEMY

Watchlist Manager
Femasys Inc Logo
Femasys Inc
NASDAQ:FEMY
Watchlist
Price: 1.27 USD -4.51% Market Closed
Updated: Apr 27, 2024

Femasys Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Femasys Inc
Revenue Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Femasys Inc
NASDAQ:FEMY
Revenue
$1.1m
CAGR 3-Years
1%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Revenue
$19.5B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
9%
Boston Scientific Corp
NYSE:BSX
Revenue
$14.2B
CAGR 3-Years
13%
CAGR 5-Years
8%
CAGR 10-Years
7%
Stryker Corp
NYSE:SYK
Revenue
$20.5B
CAGR 3-Years
13%
CAGR 5-Years
9%
CAGR 10-Years
9%
Abbott Laboratories
NYSE:ABT
Revenue
$40.3B
CAGR 3-Years
3%
CAGR 5-Years
6%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Revenue
$7.3B
CAGR 3-Years
17%
CAGR 5-Years
14%
CAGR 10-Years
13%

Femasys Inc
Revenue Breakdown

Breakdown by Geography
Femasys Inc

Not Available

Breakdown by Segments
Femasys Inc

Total Revenue: 1.1m USD
100%
Pressure Management Device Evaluates The Wome...: 1.1m USD
100%

See Also

What is Femasys Inc's Revenue?
Revenue
1.1m USD

Based on the financial report for Dec 31, 2023, Femasys Inc's Revenue amounts to 1.1m USD.

What is Femasys Inc's Revenue growth rate?
Revenue CAGR 3Y
1%

Over the last year, the Revenue growth was -11%. The average annual Revenue growth rates for Femasys Inc have been 1% over the past three years .